Erin Duffy and the Roller Coaster of Antibiotic Development
Dec 19, 2022•48 min•Season 3Ep. 2
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode of Superbugs Unplugged, our guest, Dr. Erin Duffy, discusses the global health threat of antimicrobial resistance (AMR), and why and how her non-profit, CARB-X, is investing in diverse products to help overcome common challenges faced in Low- and Middle-Income Countries (LMICs). Dr. Duffy is the Chief of R&D at CARB-X, a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat resistant bacterial
infections. Prior to CARB-X, Dr. Duffy served as Chief Scientific Officer of Melinta Therapeutics.
For the best experience, listen in Metacast app for iOS or Android